Only 5 patients stopped the trial from gastrointestinal side effects and only 5% of the 9mg and 12mg arms had to stop the trial for any adverse events
Research suggests a minimum of 26 weeks for meaningful visceral fat reduction with Tesamorelin, so plan for at least a 6-month combined protocol
& Waxman, S
Additional testing includes stability assessment under defined storage and handling conditions
Preclinical studies have demonstrated that TMAO can induce apoptosis in various target cells, such as human aortic vascular smooth muscle cells, 158 pancreatic acinous cells, renal tubular epithelial cells, 159 human aortic endothelial cells, 160,161 and neurons, 119 contributing to the development and progression of cardiovascular, renal, neurological, and pancreatic diseases
If your vision does not stabilize within a few weeks of starting or adjusting your medication, schedule an appointment